Company’s market cap , boosted by uptrend sales across its markets. Quest Diagnostics Incorporated risk and performance value beta stands at 0.6 indicating that traders can anticipate a more steady return throughout the economic cycle.
Quest Diagnostics Incorporated PE of 20.66 suggests that the stock is clearly over priced right now and market momentum suggest market might be overpricing Quest Diagnostics Incorporated stock , thought its costly investors sentiments points to buy.
And straight forward measure at 27.75X its sector Healthcare appears to be undervalued by over -7.09. Relative trade-off between the price of a stock and the earnings prospects stands at 2.93 times, further In terms of expected growth , PE is high, in contrary the business doesn’t have a high enough growth rate to justify its P /E. compared to sector average PEG at 2.66 current prices seem to be indications of bargain in terms of to fair value .
Improving ROA, means operating margins and profitability turnover ratios seems to be taking shape . Company is expected see increased growth of 17.2, but has to be noted that analyst predictions can often go wrong , also estimated EPS supports boosted earnings above current PE of 20.66.
With forward PE of 17.2, Quest Diagnostics Incorporated is set for downtrend EPS for the fiscal , primarily as per forecast by one street firm Quest Diagnostics Incorporated earnings over the next fiscal shows signs of down turn ..
Firm is holding strong assets on book which is backed by PB of 2.83. Current DGX prices are moving within a sideways range rather than trending up or down.
Roe indicates that the firm is boosting its ability to generate more profit with less capital . Healthcare firms are on the down this year , resulting in a grim EPS outlook at -7.10%.
Currently the Health Care index is trading at 8433.14 with -13.11 changeThe Health Care rally further compounded as the money flow clocked 1.77x with down tick of $4252.38mn triggering non-yielding $3704.18mn up ticks. Block trades acted as a tailwind, coming in at $-556.38mn and $623.30mn and $1179.67mn of tick ups and tick downs respectively.
Quest Diagnostics Incorporated is stuck at 200DMA , unable to break above from resistance levels at 96.35. DGX current assets to present liabilities reported at 1.5. With Quick R at 1.4 DGX liquidity position is stable , and Quest Diagnostics Incorporated has ability to meet its short term contract with its most liquid assets.
Quest Diagnostics Incorporated is now trading 10.04% higher its 52W low . Current bullish surge suggests company could enjoy further stock value growth. Quest Diagnostics Incorporated is trending to out phase current 20.66 PE by 7.04% in the next 5 years YOY .